- Home
- KE
as 07-26-2024 4:00pm EST
Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it derives a majority of revenue from the United States.
| Founded: | 1961 | Country: | United States |
| Employees: | N/A | City: | JASPER |
| Market Cap: | 557.3M | IPO Year: | N/A |
| Target Price: | $33.50 | AVG Volume (30 days): | 113.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 1.28 | EPS Growth: | -31.18 |
| 52 Week Low/High: | $19.62 - $31.43 | Next Earning Date: | 08-14-2024 |
| Revenue: | $1,780,493,000 | Revenue Growth: | 4.69% |
| Revenue Growth (this year): | -2.27% | Revenue Growth (next year): | 3.59% |
Latest Kimball Electronics Inc. News
KE Breaking Stock News: Dive into KE Ticker-Specific Updates for Smart Investing
GlobeNewswire
10 days ago
Gateway Group Announces Preliminary Sponsors and Additional Presenting Companies for September Gateway Conference
Simply Wall St.
12 days ago
Kimball Electronics, Inc. (NASDAQ:KE) On An Uptrend: Could Fundamentals Be Driving The Stock?
Simply Wall St.
a month ago
Kimball Electronics (NASDAQ:KE) shareholders have earned a 7.2% CAGR over the last five years
Yahoo Finance Video
2 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
GlobeNewswire
2 months ago
Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis
Reuters
2 months ago
California seeks company profits in Big Oil climate lawsuit
USA TODAY
2 months ago
S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead
GlobeNewswire
2 months ago
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
Compare KE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "KE Kimball Electronics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.